Medicine & TechnologyCRISPR, introduced by Doudna and Charpentier 11 years ago, gains FDA approval for gene-editing, a groundbreaking advance in treating genetic diseases. Continue reading to learn more about the world's first gene-editing treatment for human illness.
Medicine regulators greenlight the first CRISPR therapy, Casgevy, for genetic blood disorders. Explore its approval, mechanism, and details in this article.
About 40% of the catfish in the US farms die from disease before they even hatch due to infection. Check out how an alligator gene could protect them and prevent a mass die-off.
A three-year post-post procedure reveals almost a hundred percent of patients treated with CRISPR got cured of two blood disorders. Read to know more about it.
Bioengineers reimagine the CRISPR system as a Swiss Army knife by repurposing it to make a mini version for easier cell engineering and gene therapy to treat rheumatoid arthritis and other diverse ailments.
Two innovation studies published recently demonstrated the first successful precision breeding of sugarcane through the use of CRISPR/Cas9 genome editing, a far more targeted and effective way of developing new varieties.
Scientists enhanced a gene-editing treatment's form through the development of an experimental therapy that looks to hold a great potential to treat bad cholesterol.
A new CRISPR-based technology for genome editing called prime editing is more efficient and reliable compared to old techniques, potentially curing 89% of all known genetic conditions.
Three major universities are now engaged in a patent lawsuit to protect their rights to use genome editing technology called CRISPR-Cas9. The fallout will have far more impact than the simple settling of ownership and intellectual property rights, however; experts believe that CRISPR-Cas9 may be the most efficient route toward a ticking off items on a laundry list of amazing biotechnological discoveries.